The Prostate

Cover image for Vol. 74 Issue 7

Early View (Online Version of Record published before inclusion in an issue)

Edited By: John T. Isaacs

Impact Factor: 3.843

ISI Journal Citation Reports © Ranking: 2012: 9/73 (Urology & Nephrology); 39/122 (Endocrinology & Metabolism)

Online ISSN: 1097-0045

VIEW

  1. 1 - 13
  1. Original Articles

    1. Inhibition of RSK/YB-1 signaling enhances the anti-cancer effect of enzalutamide in prostate cancer

      Masaki Shiota, Akira Yokomizo, Ario Takeuchi, Momoe Itsumi, Kenjiro Imada, Eiji Kashiwagi, Junichi Inokuchi, Katsunori Tatsugami, Takeshi Uchiumi and Seiji Naito

      Article first published online: 17 APR 2014 | DOI: 10.1002/pros.22813

  2. Review Articles

    1. Notch signaling in prostate cancer: A moving target

      Filipe L. F. Carvalho, Brian W. Simons, Charles G. Eberhart and David M. Berman

      Article first published online: 16 APR 2014 | DOI: 10.1002/pros.22811

  3. Original Articles

    1. KLF9, a transcription factor induced in flutamide-caused cell apoptosis, inhibits AKT activation and suppresses tumor growth of prostate cancer cells

      Pengliang Shen, Jiabin Sun, Guiqin Xu, Li Zhang, Zhaojuan Yang, Suhua Xia, Yang Wang, Yongzhong Liu and Guowei Shi

      Article first published online: 16 APR 2014 | DOI: 10.1002/pros.22812

    2. Targeting ribosomal S6 kinases/Y-box binding protein-1 signaling improves cellular sensitivity to taxane in prostate cancer

      Masaki Shiota, Momoe Itsumi, Akira Yokomizo, Ario Takeuchi, Kenjiro Imada, Eiji Kashiwagi, Junichi Inokuchi, Katsunori Tatsugami, Takeshi Uchiumi and Seiji Naito

      Article first published online: 12 APR 2014 | DOI: 10.1002/pros.22799

    3. You have full text access to this OnlineOpen article
      Clinical presentation of prostate cancer in Black South Africans

      Elizabeth A. Tindall, L. Richard Monare, Desiree C. Petersen, Smit van Zyl, Rae-Anne Hardie, Alpheus M. Segone, Philip A. Venter, M.S. Riana Bornman and Vanessa M. Hayes

      Article first published online: 9 APR 2014 | DOI: 10.1002/pros.22806

  4. Review Articles

    1. The 20th Annual Prostate Cancer Foundation Scientific Retreat report

      Andrea K. Miyahira, Jonathan W. Simons and Howard R. Soule

      Article first published online: 9 APR 2014 | DOI: 10.1002/pros.22808

  5. Original Articles

    1. Torc1/Torc2 inhibitor, Palomid 529, enhances radiation response modulating CRM1-mediated survivin function and delaying DNA repair in prostate cancer models

      Giovanni Luca Gravina, Francesco Marampon, David Sherris, Francesca Vittorini, Ernesto Di Cesare, Vincenzo Tombolini, Andrea Lenzi, Emmanuele A. Jannini and Claudio Festuccia

      Article first published online: 8 APR 2014 | DOI: 10.1002/pros.22804

    2. Proteomic analysis of patient tissue reveals PSA protein in the stroma of benign prostatic hyperplasia

      Katherine J. O'Malley, Kurtis Eisermann, Laura E. Pascal, Anil V. Parwani, Tsuyoshi Majima, Lara Graham, Katherine Hrebinko, Marie Acquafondata, Nicolas A. Stewart, Joel B. Nelson, Naoki Yoshimura and Zhou Wang

      Article first published online: 7 APR 2014 | DOI: 10.1002/pros.22807

    3. Interleukin-17 promotes development of castration-resistant prostate cancer potentially through creating an immunotolerant and pro-angiogenic tumor microenvironment

      Qiuyang Zhang, Sen Liu, Qingsong Zhang, Zhenggang Xiong, Alun R. Wang, Leann Myers, Jonathan Melamed, Wendell W. Tang and Zongbing You

      Article first published online: 1 APR 2014 | DOI: 10.1002/pros.22805

  6. Rapid Communications

    1. Androgen withdrawal fails to induce detectable tissue hypoxia in the rat prostate

      Sietze Regter, Mohammad Hedayati, Yonggang Zhang, Haoming Zhou, Susan Dalrymple, Cameron J. Koch, John T. Isaacs and Theodore L. DeWeese

      Article first published online: 27 MAR 2014 | DOI: 10.1002/pros.22803

  7. Original Articles

    1. Elevated IL-8, TNF-α, and MCP-1 in men with metastatic prostate cancer starting androgen-deprivation therapy (ADT) are associated with shorter time to castration-resistance and overall survival

      Jaya Sharma, Kathryn P. Gray, Lauren C. Harshman, Carolyn Evan, Mari Nakabayashi, Raina Fichorova, Jennifer Rider, Lorelei Mucci, Philip W. Kantoff and Christopher J. Sweeney

      Article first published online: 26 MAR 2014 | DOI: 10.1002/pros.22788

    2. Inhibition of CYP17A1 activity by resveratrol, piceatannol, and synthetic resveratrol analogs

      Agneta Oskarsson, Carmela Spatafora, Corrado Tringali and Åsa Ohlsson Andersson

      Article first published online: 9 MAR 2014 | DOI: 10.1002/pros.22801

VIEW

  1. 1 - 13

SEARCH

SEARCH BY CITATION